Adaptation: Pattern Recognition Prosthetic Control

Sponsor
Coapt, LLC (Industry)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04272489
Collaborator
Congressionally Directed Medical Research Programs (U.S. Fed)
20
1
2
9.4
2.1

Study Details

Study Description

Brief Summary

Many different factors can degrade the performance of an upper limb prosthesis users control with electromyographic (EMG)-based pattern recognition control. Conventional control systems require frequent recalibration in order to achieve consistent performance which can lead to prosthetic users choosing to wear their device less. This study investigates a new adaptive pattern recognition control algorithm that retrains, rather than overwrite, the existing control system each instance users recalibrate. The study hypothesis is that such adaptive control system will lead to more satisfactory prosthesis control thus reducing the need for recalibration and increasing how often users wear their device. Participants will wear their prosthesis as they would normally at-home using each control system (adaptive and non-adaptive) for an 8-week period with an intermittent 1-week washout period (17 weeks total). Prosthetic usage will be monitored during each period in order to compare user wear time and recalibration frequency when using adaptive or non-adaptive control. Participants will also play a set of virtual games on a computer at the start (0-months), mid-point (1-months) and end (2-months) of each period that will test their ability to control prosthesis movement using each control system. Changes in user performance will be evaluated during each period and compared between the two control systems. This study will not only evaluate the effectiveness of adaptive pattern recognition control, but it will be done at-home under typical and realistic prosthetic use conditions.

Condition or Disease Intervention/Treatment Phase
  • Device: EMG-Pattern Recognition Controller
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
The study is a randomized crossover home trial consisting of two 8-week periods with an intermittent 1-week washout period (17 weeks total). Participants will use either adaptive control or non-adaptive control during the first 8-week period then switch to using the opposite control style during the second 8-week period.The study is a randomized crossover home trial consisting of two 8-week periods with an intermittent 1-week washout period (17 weeks total). Participants will use either adaptive control or non-adaptive control during the first 8-week period then switch to using the opposite control style during the second 8-week period.
Masking:
Single (Participant)
Masking Description:
Participants will not be explicitly informed which type of control they will be using during each 8-week period.
Primary Purpose:
Treatment
Official Title:
Efficacy of Control System Adaptation in Improving Upper-Extremity Prosthetic Limb Wear Time in a Real-World Setting, a Randomized Crossover Trial
Actual Study Start Date :
Dec 17, 2020
Anticipated Primary Completion Date :
Sep 29, 2021
Anticipated Study Completion Date :
Sep 29, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Adaptive Control

The adaptive control system updates the pattern recognition control algorithm by incorporating new EMG data each instance the prosthetic user recalibrates their device.

Device: EMG-Pattern Recognition Controller
Using an electromyographic (EMG)-based pattern recognition controller to move an upper limb prosthetic device in a home trial.
Other Names:
  • Coapt Complete Control Gen2
  • Active Comparator: Non-Adaptive Control

    The conventional, non-adaptive control systems resets the pattern recognition control algorithm by deleting old EMG data each instance the prosthetic user recalibrate their device.

    Device: EMG-Pattern Recognition Controller
    Using an electromyographic (EMG)-based pattern recognition controller to move an upper limb prosthetic device in a home trial.
    Other Names:
  • Coapt Complete Control Gen2
  • Outcome Measures

    Primary Outcome Measures

    1. Differences in prosthetic wear time [We will record total prosthetic wear time during the course of each in-home 8-week period.]

      We will record each instance participants turn on or off their pattern recognition device throughout the home trial. Prosthetic wear time is defined as the cumulative amount of time participants keep their pattern recognition device turned on during the course of each in-home 8-week period. We will perform a statistical analysis to compare wear time when using each type of pattern recognition control system (adaptive and non-adaptive). We will complete repeated measures analysis of variance with subject as a random factor, order of control system used as a fixed variable, and wear time as a fixed variable.

    Secondary Outcome Measures

    1. Differences in calibration frequency [We will record calibration frequency during the course of each in-home 8-week period.]

      We will record each instance participants recalibrate their pattern recognition device throughout the home trial. We will perform a statistical analysis to compare the frequency of calibrations when using each control system (adaptive and non-adaptive). We will complete a repeated measures analysis of variance with subject as a random factor, order of control system used as a fixed variable, and wear time as a fixed variable.

    2. Changes in virtual game performance [Participants will complete the virtual games at the start (0-months), mid-point (1-months) and end (2-months) of each in-home 8-week period.]

      Participants will complete two virtual games called Simon Says and In-the-Zone using the Coapt Complete ControlRoom desktop application. Both games will test how well participants control motion of virtual objects using their pattern recognition device. We will measure their overall control performance by computing completion rate, movement time, path efficiency. We will perform a statistical analysis to compare virtual game performance when using each control system. We will complete a repeated measures analysis of variance with subject as a random factor, order of pattern recognition control system used as a fixed variable, and each performance metric as a fixed variable.

    3. RIC's Orthotics Prosthetics User Survey [Participants will complete the OPUS at the start (0-months) and end (2-months) of each 8-week period. of each in-home 8-week period.]

      Participants will complete the Upper Extremity Functional Status module from RIC's Orthotics Prosthetics User Survey (OPUS). The OPUS asks prosthetic users to rate the level of difficulty (from very easy to very difficult) in performing upper arm/hand functions using their pattern recognition device. Survey data will be evaluated using rating scale analysis (Rasch model).

    4. Prosthetic user survey [Participants will complete the survey at the end of their study participation (17 weeks).]

      Participants will complete a survey or phone interview to provide feedback on which control system they prefer between adaptive or non-adaptive. Participants will inform whether they prefer the control system they used in the first or second 8-week period.

    5. Differences in classification accuracy [We will record classification accuracy at the start (0-months), mid-point (1-months) and end (2-months) of each in-home 8-week period.]

      Participants will be instructed to use their pattern recognition device to make a set of independent prosthesis motions and hold each motion for 3 seconds. For each motion, we will record the output motion class determined by their pattern recognition classifier every 50 ms. We will measure the performance of their classier when using each control system (adaptive and non-adaptive) by computing the classification accuracy which is defined as the number of correct classifications over the total number of classifications for each motion. We will perform a statistical analysis to compare classification accuracy when using each control system. We will complete a repeated measures analysis of variance with subject as a random factor, order of pattern recognition control system used as a fixed variable, and classification accuracy as a fixed variable.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Subjects have an upper-limb difference (congenital or acquired) at the transradial (between the wrist and elbow), elbow disarticulation (at the elbow), transhumeral (between the elbow and shoulder), or shoulder disarticulation (at the shoulder) level.

    • Subjects are suitable to be, or already are, a Coapt pattern recognition user (Coapt Complete Control Gen 2).

    • Subjects are between the ages of 18 and 70.

    Exclusion Criteria:
    • Subjects with significant cognitive deficits or visual impairment that would preclude them from giving informed consent or following instructions during the experiments, or the ability to obtain relevant user feedback discussion.

    • Subjects who are non-English speaking.

    • Subjects who are pregnant.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Coapt, LLC Chicago Illinois United States 60654

    Sponsors and Collaborators

    • Coapt, LLC
    • Congressionally Directed Medical Research Programs

    Investigators

    • Principal Investigator: Blair Lock, MScE, Coapt, LLC

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Coapt, LLC
    ClinicalTrials.gov Identifier:
    NCT04272489
    Other Study ID Numbers:
    • 120190044
    • W81XWH-17-1-0645
    First Posted:
    Feb 17, 2020
    Last Update Posted:
    Mar 1, 2021
    Last Verified:
    Feb 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Coapt, LLC
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 1, 2021